Alexandra L. Massa
Translational scientist with 10+ years of experience at the intersection of life sciences, immuno-oncology, and venture capital
Hire this person
Send a job offer directly to this candidate
About
Translational scientist with 10+ years of experience at the intersection of life sciences, immuno-oncology, and venture capital. PhD Innovation Fellow in Cancer Biology with a strong foundation in immunotherapy, genomics, and startup development. Exposure to early-stage investing, due diligence, financial and market analysis through fellowships at Borealis Ventures and Dartmouth's innovation ecosystem.
Adept at translating complex scientific concepts into commercial opportunities. Passionate about advancing human and animal-focused innovations and supporting next-generation companies and founders.
Experience
PhD Innovation Fellow, Cancer Biology - Dartmouth Cancer Center - Lebanon, NH
(2018-01 - 2024-12)
- Recipient of PhD fellowship for demonstrating entrepreneurial promise; receive up to five years of financial support ($100,000 value) including additional funding ($10,000) to support research culminating in proposed startup pitch to external advisors; learn business & financial modeling skills through supplementary coursework, experiential learning, & mentorship from entrepreneurs & investors
- Research quantified endogenous retroviral (ERV) expression in solid tumors with implications for tumor immunity & immunotherapy; also studied epigenetic regulation in cancer to inform prognosis & therapeutic strategies
- Pitched potential startup business plan, including technology build-out, IP, & financials, from dissertation work to industry executives and investors as part of innovation fellowship capstone
- Collaborated extensively with cross-disciplinary investigators; presented regularly at team & program-wide meetings
Venture Fellow, Life Sciences - Borealis Ventures - Hanover, NH
(2019-01 - 2023-12)
- Sourced & evaluated investment opportunities across human & animal health, conducted due diligence & financial modeling, monitored current portfolio companies, & engaged with company founders & executives
- Invited panelist for the Spring 2023 Dartmouth Entrepreneurs Forum, "Fundraising for your startup in uncertain times: Creative insights to find the resources you need"
- Market analysis & company landscape for new animal health-focused fund, informing thesis & mandate
- Business redesign for UK-based portco platform technology, addressing technical, market & commercial implications. Collaborated with CEO to create technology pivot strategy, modernizing & expanding the applications of their platform to reach a wider customer base, increasing revenue & identity in US market. Conducted end-market surveys & in-depth interviews, as well as analysis of competitor products to better understand customer needs & pain-points
- Newco spinout from current portfolio asset & initial investment, entry into the comparative medicine market. Estimated market demand & strategy to build out newco asset portfolio, including necessary licensing, acquisition targets, & regulatory considerations. Built top-down financial model, including projected revenue, DCF, & exit opportunities to make investment recommendation
Startup Accelerator Team Lead & Student Leadership Board - Magnuson Center for Entrepreneurship - Hanover, NH
(2020-01 - 2023-12)
- Selected participant in 10-week Dartmouth Cancer Accelerator 1) CAR T cell therapy platform & 2) endogenous retrovirus (ERV)-based technology. Evaluated broader & target immune-oncology market, competition, & IP landscape. Created value proposition, business & product development plan. Prepared & delivered final pitch(s) to the external review panel of biotech investors & executives
- Served on Magnuson's student leadership board for 1 year. Implemented graduate-school-wide entrepreneurship social/networking events to better engage the Dartmouth graduate school community. Assisted with Venture Capital Investment Competition (VCIC). Participated as invited moderator for Dartmouth Entrepreneurs Forum healthcare fireside chat & assisted as forum organizer for San Francisco event
Sr. Research Associate, Cancer Immunology & Vaccine Technology - Neon Therapeutics (acquired by BioNTech) - Cambridge, MA
(2016-01 - 2018-12)
- Explored neoantigen-based therapeutic vaccine strategies for solid cancers. Designed & executed pre-clinical immunogenicity & tumor control assays in mouse models, including dose/regimen optimization, adjuvant selection, & downstream immune monitoring
- Contributed to the development of a high-throughput functional T cell assay for vaccine candidate screening
- Collaborated extensively with internal cross-disciplinary teams & external laboratories/companies. Presented at both core team & company-wide meetings frequently
Research Technician, Immunology - Ragon Institute of MGH, MIT, & Harvard - Cambridge, MA
(2014-01 - 2016-12)
- Defined qualities of HIV-specific patient T cells & their role in neutralizing antibody development. Developed expertise in multicolor flow cytometry, mass cytometry (CyTOF), & immune-based assays. Trained new hires & visiting professionals in lab-specific protocols & techniques
Research Intern, Cancer Metabolism - Agios Pharmaceuticals - Cambridge, MA
(2014-06 - 2014-08)
- Explored combination therapies targeting mutant isocitrate dehydrogenase (IDH) activity in cancer metabolism. Prepared project summary & poster to present to the company at the end of the summer
Education
PhD - Cancer Biology - Dartmouth College, Guarini Graduate School of Arts & Sciences (2018-01 - 2025-12)
BS & BA - Neuroscience & Chemistry - Stonehill College (2010-01 - 2014-12)